GFM
GF Fund Management Portfolio holdings
AUM
$4.97B
This Quarter Return
-4%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$4.26B
AUM Growth
-$362M
(-7.8%)
Cap. Flow
-$2.11M
Cap. Flow
% of AUM
-0.05%
Top 10 Holdings %
Top 10 Hldgs %
43.71%
Holding
683
New
46
Increased
475
Reduced
93
Closed
17
Top Buys
| 1 |
Philip Morris
PM
|
$43M |
| 2 |
Amazon
AMZN
|
$24.3M |
| 3 |
Palantir
PLTR
|
$16.8M |
| 4 |
Yum China
YUMC
|
$14.4M |
| 5 |
Hims & Hers Health
HIMS
|
$10.9M |
Top Sells
| 1 |
Pinduoduo
PDD
|
$40.6M |
| 2 |
NVIDIA
NVDA
|
$25.7M |
| 3 |
KE Holdings
BEKE
|
$14.3M |
| 4 |
Meta Platforms (Facebook)
META
|
$13.3M |
| 5 |
Coca-Cola
KO
|
$9.83M |
Sector Composition
| 1 | Technology | 42.51% |
| 2 | Consumer Discretionary | 16.26% |
| 3 | Communication Services | 14.17% |
| 4 | Healthcare | 7.8% |
| 5 | Consumer Staples | 6.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Solventum
SOLV
$12.6B
| $263K | 0.01% |
3,461
| – | – |
|
302
W.P. Carey
WPC
$14.9B
| $262K | 0.01% |
4,145
+168
| +4% | +$10.6K |
|
|
303
Coca-Cola
KO
$292B
| $259K | 0.01% |
3,617
-137,218
| -97% | -$9.83M |
|
304
Calumet Specialty Products
CLMT
$1.55B
| $253K | 0.01% |
19,990
-791
| -4% | -$10K |
|
305
Camden Property Trust
CPT
$11.9B
| $247K | 0.01% |
2,021
+83
| +4% | +$10.2K |
|
306
Medpace
MEDP
$13.7B
| $243K | 0.01% |
796
+143
| +22% | +$43.6K |
|
307
Regency Centers
REG
$13.4B
| $241K | 0.01% |
3,266
+133
| +4% | +$9.81K |
|
308
Ascendis Pharma
ASND
$12.5B
| $241K | 0.01% |
1,544
+278
| +22% | +$43.3K |
|
309
Par Pacific Holdings
PARR
$1.72B
| $240K | 0.01% |
16,799
-665
| -4% | -$9.48K |
|
310
American Homes 4 Rent
AMH
$12.9B
| $238K | 0.01% |
6,288
+304
| +5% | +$11.5K |
|
311
Celestica
CLS
$27.9B
| $236K | 0.01% |
+3,000
| New | +$236K |
|
312
Bio-Techne
TECH
$8.46B
| $230K | 0.01% |
3,929
| – | – |
|
313
Equity Lifestyle Properties
ELS
$12B
| $229K | 0.01% |
3,438
+218
| +7% | +$14.5K |
|
314
BioNTech
BNTX
$27B
| $229K | 0.01% |
2,514
+453
| +22% | +$41.3K |
|
315
Halozyme
HALO
$8.76B
| $208K | ﹤0.01% |
3,258
+587
| +22% | +$37.5K |
|
316
CVR Energy
CVI
$3.16B
| $197K | ﹤0.01% |
10,156
-402
| -4% | -$7.8K |
|
317
Omega Healthcare
OHI
$12.7B
| $195K | ﹤0.01% |
5,113
+428
| +9% | +$16.3K |
|
318
Jazz Pharmaceuticals
JAZZ
$7.86B
| $192K | ﹤0.01% |
1,548
+279
| +22% | +$34.6K |
|
319
Henry Schein
HSIC
$8.42B
| $192K | ﹤0.01% |
2,801
| – | – |
|
320
Boston Properties
BXP
$12.2B
| $191K | ﹤0.01% |
2,845
+119
| +4% | +$8K |
|
|
TEM
321
Tempus AI, Inc. Class A Common Stock
TEM
$13.8B
| $188K | ﹤0.01% |
3,902
+702
| +22% | +$33.9K |
|
322
Host Hotels & Resorts
HST
$12B
| $188K | ﹤0.01% |
13,240
+475
| +4% | +$6.75K |
|
323
Roivant Sciences
ROIV
$8.82B
| $188K | ﹤0.01% |
18,641
+3,356
| +22% | +$33.9K |
|
324
Charles River Laboratories
CRL
$8.07B
| $185K | ﹤0.01% |
1,231
| – | – |
|
325
Madrigal Pharmaceuticals
MDGL
$9.65B
| $185K | ﹤0.01% |
558
+100
| +22% | +$33.1K |
|